| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |